Cirrhosis, familial
MONDO:0007329Cirrhosis in which no causative agent can be identified.
Also known as: cirrhosis, familial, cryptogenic cirrhosis, hereditary cirrhosis of liver, Indian childhood cirrhosis, Sen syndrome, cirrhosis, Noncryptogenic, susceptibility to, cirrhosis, cryptogenic, cirrhosis, familial, with pulmonary hypertension
82 clinical trials for this condition and its sub-types, 4 tagged with Cirrhosis, familial itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cirrhosis, familial
-
Primary biliary cholangitis 74 trials
5 sub-types
- Primary biliary cholangitis 1 3 trials
- Primary biliary cholangitis 2 0 trials
- Primary biliary cholangitis 3 0 trials
- Primary biliary cholangitis 4 0 trials
- Primary biliary cholangitis 5 0 trials
-
Isolated congenital hepatic fibrosis 2 trials
-
New drug hopes to tackle MASH cirrhosis
Disease control Recruiting nowThis study tests a new medicine called BI 3802876 in adults with compensated cirrhosis caused by MASH (a type of fatty liver disease). The main goal is to see if the drug is safe and how the body handles it. Participants receive either the drug or a placebo as an infusion, and ar…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study aims to predict who gets liver cancer from alcohol
Knowledge-focused Recruiting nowThis study looks at 1,000 people with alcohol-related liver disease to understand how their genes and drinking habits together raise the risk of liver cancer. Researchers will analyze DNA and lifestyle factors to create a risk score that could help doctors decide who needs regula…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Can genes predict liver cancer in fatty liver patients?
Knowledge-focused Recruiting nowThis study looks at how certain genes increase the risk of liver cancer (hepatocellular carcinoma) in people with nonalcoholic fatty liver disease (NAFLD). Researchers will follow 500 adults aged 45-75 with NAFLD to understand how genetic factors and lifestyle interact. The goal …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC